Chat with us, powered by LiveChat

Loading...

Healthcare Finance Solutions Market Report

RA01272

Healthcare Finance Solutions Market, by Equipment (Diagnostic/Imaging Equipment, Specialty Beds, Surgical Instruments, Decontamination Equipment, IT Equipment), Healthcare Facility (Hospitals & Health Systems, Outpatient Imaging Centers, Outpatient Surgery Centers, Physician Practices & Outpatient Clinics, Diagnostic Laboratories, Urgent Care Clinics, Skilled Nursing Facilities, Pharmacies, Other Healthcare Providers), Service (Equipment and Technology Finance, Working Capital Finance, Project Finance Solutions, Corporate Lending): Global Opportunity Analysis and Industry Forecast, 2020-2027

RA01272

Pages: 140

Jan 2023

The global healthcare finance solutions market is estimated to surpass $193,141.6 million by 2027, exhibiting a CAGR of 7.6% from 2020 to 2027.

The report provides all-inclusive analysis of global healthcare finance solutions market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape.

The report emphasizes current market scenario and future trends of the global healthcare finance solutions market which gleaned from the impact of various market dynamics such as drivers, challenges & restraints, lucrative opportunities. The report also highlights the key forces that are shaping the market. Besides, the report provides Porter’s five forces analysis which precisely underlines the impact of key forces on the global healthcare finance solutions market.

In addition, the report provides market size and forecast scrutinizing global healthcare finance solutions market through different segments. The report highlights the geographical market analysis of these segments and each segment is thoroughly studied at regional as well as country level to get clearer picture of the global healthcare finance solutions market. In the report, the global healthcare finance solutions market is divided into four major regions including North America, Europe, Asia-Pacific, and LAMEA. These regions are further divided into major countries to cover healthcare finance solutions market landscape in respective regions.

Furthermore, competitive scenario of the global healthcare finance solutions market is covered in the report. Major players functioning in the global healthcare finance solutions market are also studied to understand their position and competitive strengths in the industry. The major company profiles covered in the report include various company’s datum such as brief overview, recent financials, main executives, adoption of key growth strategies, novel advancements or initiatives to sustain and expand their position in the global healthcare finance solutions market, and others.

Research Methodology

Research Dive offers its clients extensive research and analysis gleaned from wide variety of factual inputs that largely includes interview with participants of the industry, reliable data & statistics, and regional intelligence. The in-house experts of the industry play a crucial role in designing analytic tools and models, tailor-made to the requests of an industry segment. The data and statistics are sterilized with these analytical tools and models, which enhances the accuracy of our advice and recommendations.

This research report is delivered by Research Dive by conducting long hours of discussions and interviews, with a broad range of stakeholders, which includes upstream and downstream participants. Our analysts have performed a mix of primary and secondary research for the market estimations and forecasts. A number of product type literatures, industry releases, annual reports, and other related documents of major participants of the industry have been reviewed, to better understand the global healthcare finance solutions market scenario. The initial phase of our in-depth study, where we perform wide-range data mining, referring to proficient & verified data sources such as independent studies, medical journals, technical journals, releases by trade association, materials published by government & regulatory authorities, and other.

KEY MARKET BENEFITS

  • This report is a compilation of detailed study, information, valid inputs from industry experts & industry participants across the value chain, and quantitative & qualitative assessment by analysts of the industry.
  • The report provides a comprehensive analysis along with the current trends of market during the forecast period from 2019 to 2027 to identify & comprehend the prevailing opportunities and the strategic assessment of the global healthcare finance solutions market growth.
  • The report studies the market from 2019 to 2027 and maps the qualitative impact of several industry factors on market segments as well as geographies.
  • The report provides market estimations and size which is based on in-depth analysis of recent & key developments in the healthcare finance solutions market.
  • The development strategies implemented by the key industry players are conscripted in the report to understand the competitive scenario of the global healthcare finance solutions market.

KEY MARKET SEGMENTS

The market has been studied based on the following segments:

  • Equipment: Diagnostic/Imaging Equipment, Specialty Beds, Surgical Instruments, Decontamination Equipment, IT Equipment
  • Healthcare Facility: Hospitals & Health Systems, Outpatient Imaging Centers, Outpatient Surgery Centers, Physician Practices & Outpatient Clinics, Diagnostic Laboratories, Urgent Care Clinics, Skilled Nursing Facilities, Pharmacies, Other Healthcare Providers
  • Service: Equipment and Technology Finance, Working Capital Finance, Project Finance Solutions, Corporate Lending

Region:

The global healthcare finance solutions market is divided into North America, Europe, Asia Pacific, and LAMEA.

The above-mentioned regions are further dived in countries as follows:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of LAMEA

 

KEY MARKET PLAYERS

The report covers the major players operating in the global healthcare finance solutions market that focus on advancements & innovations and geographical expansion of product portfolios to obtain a competitive edge in the market space. The major players enlisted in the report include Siemens Financial Services, Inc., Oxford Finance LLC, Thermo Fisher Scientific, Inc., General Electric Company, …., and others.

The report summarizes various aspects of all these key players that include as follows:

    1. Koninklijke Philips N.V.

    2. General Electric Company

    3. Commerce Bankshares, Inc.

    4. Siemens Financial Services, Inc.

    5. Thermo Fisher Scientific, Inc.

    6. Stryker

    7. Gemino Healthcare Finance

    8. Oxford Finance LLC

    9. TCF Capital Solutions

    10. CIT Group, Inc.

  • 1. RESEARCH METHODOLOGY

    • 1.1. Desk Research

    • 1.2. Real time insights and validation

    • 1.3. Forecast model

    • 1.4. Assumptions and forecast parameters

    • 1.5. Market size estimation

      • 1.5.1. Top-down approach

      • 1.5.2. Bottom-up approach

  • 2. REPORT SCOPE

    • 2.1. Market definition

    • 2.2. Key objectives of the study

    • 2.3. Report overview

    • 2.4. Market segmentation

    • 2.5. Overview of the impact of COVID-19 on Global Healthcare Finance Solutions Market

  • 3. EXECUTIVE SUMMARY

  • 4. MARKET OVERVIEW

    • 4.1. Introduction

    • 4.2. Growth impact forces

      • 4.2.1. Drivers

      • 4.2.2. Restraints

      • 4.2.3. Opportunities

    • 4.3. Market value chain analysis

      • 4.3.1. List of raw material suppliers

      • 4.3.2. List of manufacturers

      • 4.3.3. List of distributors

    • 4.4. Innovation & sustainability matrices

      • 4.4.1. Technology matrix

      • 4.4.2. Regulatory matrix

    • 4.5. Porter’s five forces analysis

      • 4.5.1. Bargaining power of suppliers

      • 4.5.2. Bargaining power of consumers

      • 4.5.3. Threat of substitutes

      • 4.5.4. Threat of new entrants

      • 4.5.5. Competitive rivalry intensity

    • 4.6. PESTLE analysis

      • 4.6.1. Political

      • 4.6.2. Economical

      • 4.6.3. Social

      • 4.6.4. Technological

      • 4.6.5. Environmental

    • 4.7. Impact of COVID-19 on Healthcare Finance Solutions Market

      • 4.7.1. Pre-covid market scenario

      • 4.7.2. Post-covid market scenario

  • 5. Healthcare Finance Solutions Market, By Location

    • 5.1. Overview

    • 5.2 Diagnostic/Imaging Equipment

      • 5.2.1 Definition, key trends, growth factors, and opportunities

      • 5.2.2 Market size analysis, by region, 2020-2027

      • 5.2.3 Market share analysis, by country, 2020-2027

    • 5.3 Specialty Beds

      • 5.3.1 Definition, key trends, growth factors, and opportunities

      • 5.3.2 Market size analysis, by region, 2020-2027

      • 5.3.3 Market share analysis, by country, 2020-2027

    • 5.4 Surgical Instruments

      • 5.4.1 Definition, key trends, growth factors, and opportunities

      • 5.4.2 Market size analysis, by region, 2020-2027

      • 5.4.3 Market share analysis, by country, 2020-2027

    • 5.5 Decontamination Equipment

      • 5.5.1 Definition, key trends, growth factors, and opportunities

      • 5.5.2 Market size analysis, by region, 2020-2027

      • 5.5.3 Market share analysis, by country, 2020-2027

    • 5.6 IT Equipment

      • 5.6.1 Definition, key trends, growth factors, and opportunities

      • 5.6.2 Market size analysis, by region, 2020-2027

      • 5.6.3 Market share analysis, by country, 2020-2027

    • 5.7 Research Dive Exclusive Insights

      • 5.7.1 Market attractiveness

      • 5.7.2 Competition heatmap

  • 6. Healthcare Finance Solutions Market, By Clinical Trial Phase

    • 6.1. Overview

    • 6.2 Hospitals & Health Systems

      • 6.2.1 Definition, key trends, growth factors, and opportunities

      • 6.2.2 Market size analysis, by region, 2020-2027

      • 6.2.3 Market share analysis, by country, 2020-2027

    • 6.3 Outpatient Imaging Centers

      • 6.3.1 Definition, key trends, growth factors, and opportunities

      • 6.3.2 Market size analysis, by region, 2020-2027

      • 6.3.3 Market share analysis, by country, 2020-2027

    • 6.4 Outpatient Surgery Centers

      • 6.4.1 Definition, key trends, growth factors, and opportunities

      • 6.4.2 Market size analysis, by region, 2020-2027

      • 6.4.3 Market share analysis, by country, 2020-2027

    • 6.5 Physician Practices & Outpatient Clinics

      • 6.5.1 Definition, key trends, growth factors, and opportunities

      • 6.5.2 Market size analysis, by region, 2020-2027

      • 6.5.3 Market share analysis, by country, 2020-2027

    • 6.6 Diagnostic Laboratories

      • 6.6.1 Definition, key trends, growth factors, and opportunities

      • 6.6.2 Market size analysis, by region, 2020-2027

      • 6.6.3 Market share analysis, by country, 2020-2027

    • 6.7 Urgent Care Clinics

      • 6.7.1 Definition, key trends, growth factors, and opportunities

      • 6.7.2 Market size analysis, by region, 2020-2027

      • 6.7.3 Market share analysis, by country, 2020-2027

    • 6.8 Skilled Nursing Facilities

      • 6.8.1 Definition, key trends, growth factors, and opportunities

      • 6.8.2 Market size analysis, by region, 2020-2027

      • 6.8.3 Market share analysis, by country, 2020-2027

    • 6.9 Pharmacies

      • 6.9.1 Definition, key trends, growth factors, and opportunities

      • 6.9.2 Market size analysis, by region, 2020-2027

      • 6.9.3 Market share analysis, by country, 2020-2027

    • 6.10 Other Healthcare Providers

      • 6.10.1 Definition, key trends, growth factors, and opportunities

      • 6.10.2 Market size analysis, by region, 2020-2027

      • 6.10.3 Market share analysis, by country, 2020-2027

    • 6.11 Research Dive Exclusive Insights

      • 6.11.1 Market attractiveness

      • 6.11.2 Competition heatmap

  • 7. Healthcare Finance Solutions Market, By Deployment Mode

    • 7.1. Overview

    • 7.2 Equipment and Technology Finance

      • 7.2.1 Definition, key trends, growth factors, and opportunities

      • 7.2.2 Market size analysis, by region, 2020-2027

      • 7.2.3 Market share analysis, by country, 2020-2027

    • 7.3 Working Capital Finance

      • 7.3.1 Definition, key trends, growth factors, and opportunities

      • 7.3.2 Market size analysis, by region, 2020-2027

      • 7.3.3 Market share analysis, by country, 2020-2027

    • 7.4 Project Finance Solutions

      • 7.4.1 Definition, key trends, growth factors, and opportunities

      • 7.4.2 Market size analysis, by region, 2020-2027

      • 7.4.3 Market share analysis, by country, 2020-2027

    • 7.5 Corporate Lending

      • 7.5.1 Definition, key trends, growth factors, and opportunities

      • 7.5.2 Market size analysis, by region, 2020-2027

      • 7.5.3 Market share analysis, by country, 2020-2027

    • 7.6 Research Dive Exclusive Insights

      • 7.6.1 Market attractiveness

      • 7.6.2 Competition heatmap

  • 8. Healthcare Finance Solutions Market, By Region

    • 8.1 North America

      • 8.1.1 U.S

        • 8.1.1.1 Market size analysis, By Location, 2020-2027

        • 8.1.1.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.1.1.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.1.2 Canada

        • 8.1.2.1 Market size analysis, By Location, 2020-2027

        • 8.1.2.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.1.2.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.1.3 Mexico

        • 8.1.3.1 Market size analysis, By Location, 2020-2027

        • 8.1.3.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.1.3.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.1.4 Research Dive Exclusive Insights

        • 8.1.4.1 Market attractiveness

        • 8.1.4.2 Competition heatmap

    • 8.2 Europe

      • 8.2.1 Germany

        • 8.2.1.1 Market size analysis, By Location, 2020-2027

        • 8.2.1.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.2.1.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.2.2 UK

        • 8.2.2.1 Market size analysis, By Location, 2020-2027

        • 8.2.2.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.2.2.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.2.3 France

        • 8.2.3.1 Market size analysis, By Location, 2020-2027

        • 8.2.3.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.2.3.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.2.4 Spain

        • 8.2.4.1 Market size analysis, By Location, 2020-2027

        • 8.2.4.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.2.4.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.2.5 Italy

        • 8.2.5.1 Market size analysis, By Location, 2020-2027

        • 8.2.5.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.2.5.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.2.6 Rest of Europe

        • 8.2.6.1 Market size analysis, By Location, 2020-2027

        • 8.2.6.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.2.6.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.2.7 Research Dive Exclusive Insights

        • 8.2.7.1 Market attractiveness

        • 8.2.7.2 Competition heatmap

    • 8.3 Asia-Pacific

      • 8.3.1 China

        • 8.3.1.1 Market size analysis, By Location, 2020-2027

        • 8.3.1.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.3.1.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.3.2 Japan

        • 8.3.2.1 Market size analysis, By Location, 2020-2027

        • 8.3.2.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.3.2.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.3.3 India

        • 8.3.3.1 Market size analysis, By Location, 2020-2027

        • 8.3.3.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.3.3.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.3.4 Australia

        • 8.3.4.1 Market size analysis, By Location, 2020-2027

        • 8.3.4.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.3.4.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.3.5 South Korea

        • 8.3.5.1 Market size analysis, By Location, 2020-2027

        • 8.3.5.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.3.5.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.3.6 Rest of Asia-Pacific

        • 8.3.6.1 Market size analysis, By Location, 2020-2027

        • 8.3.6.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.3.6.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.3.7 Research Dive Exclusive Insights

        • 8.3.7.1 Market attractiveness

        • 8.3.7.2 Competition heatmap

    • 8.4 LAMEA

      • 8.4.1 Brazil

        • 8.4.1.1 Market size analysis, By Location, 2020-2027

        • 8.4.1.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.4.1.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.4.2 Saudi Arabia

        • 8.4.2.1 Market size analysis, By Location, 2020-2027

        • 8.4.2.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.4.2.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.4.3 UAE

        • 8.4.3.1 Market size analysis, By Location, 2020-2027

        • 8.4.3.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.4.3.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.4.4 South Africa

        • 8.4.4.1 Market size analysis, By Location, 2020-2027

        • 8.4.4.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.4.4.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.4.5 Rest of LAMEA

        • 8.4.5.1 Market size analysis, By Location, 2020-2027

        • 8.4.5.2 Market size analysis, By Clinical Trial Phase, 2020-2027

        • 8.4.5.3 Market size analysis, By Deployment Mode, 2020-2027

      • 8.4.6 Research Dive Exclusive Insights

        • 8.4.6.1 Market attractiveness

        • 8.4.6.2 Competition heatmap

  • 9. Competitive Landscape

    • 9.1 Top winning strategies, 2020-2027

      • 9.1.1 By strategy

      • 9.1.2 By year

    • 9.2 Strategic overview

    • 9.3 Market share analysis, 2020-2027

  • 10. Company Profiles

    • 10.1 Koninklijke Philips N.V.

      • 10.1.1 Overview

      • 10.1.2 Business segments

      • 10.1.3 Product portfolio

      • 10.1.4 Financial performance

      • 10.1.5 Recent developments

      • 10.1.6 SWOT analysis

    • 10.2 General Electric Company

      • 10.2.1 Overview

      • 10.2.2 Business segments

      • 10.2.3 Product portfolio

      • 10.2.4 Financial performance

      • 10.2.5 Recent developments

      • 10.2.6 SWOT analysis

    • 10.3 Commerce Bankshares, Inc.

      • 10.3.1 Overview

      • 10.3.2 Business segments

      • 10.3.3 Product portfolio

      • 10.3.4 Financial performance

      • 10.3.5 Recent developments

      • 10.3.6 SWOT analysis

    • 10.4 Siemens Financial Services, Inc.

      • 10.4.1 Overview

      • 10.4.2 Business segments

      • 10.4.3 Product portfolio

      • 10.4.4 Financial performance

      • 10.4.5 Recent developments

      • 10.4.6 SWOT analysis

    • 10.5 Thermo Fisher Scientific, Inc.

      • 10.5.1 Overview

      • 10.5.2 Business segments

      • 10.5.3 Product portfolio

      • 10.5.4 Financial performance

      • 10.5.5 Recent developments

      • 10.5.6 SWOT analysis

    • 10.6 Stryker

      • 10.6.1 Overview

      • 10.6.2 Business segments

      • 10.6.3 Product portfolio

      • 10.6.4 Financial performance

      • 10.6.5 Recent developments

      • 10.6.6 SWOT analysis

    • 10.7 Gemino Healthcare Finance

      • 10.7.1 Overview

      • 10.7.2 Business segments

      • 10.7.3 Product portfolio

      • 10.7.4 Financial performance

      • 10.7.5 Recent developments

      • 10.7.6 SWOT analysis

    • 10.8 Oxford Finance LLC

      • 10.8.1 Overview

      • 10.8.2 Business segments

      • 10.8.3 Product portfolio

      • 10.8.4 Financial performance

      • 10.8.5 Recent developments

      • 10.8.6 SWOT analysis

    • 10.9 TCF Capital Solutions

      • 10.9.1 Overview

      • 10.9.2 Business segments

      • 10.9.3 Product portfolio

      • 10.9.4 Financial performance

      • 10.9.5 Recent developments

      • 10.9.6 SWOT analysis

    • 10.10 CIT Group, Inc.

      • 10.10.1 Overview

      • 10.10.2 Business segments

      • 10.10.3 Product portfolio

      • 10.10.4 Financial performance

      • 10.10.5 Recent developments

      • 10.10.6 SWOT analysis

Purchase Options

Personalize this research

  • Triangulate with your own data
  • Request your format and definition
  • Get a deeper dive on a specific application, geography, customer or competitor
10% Off on Customization
Contact Us

Customers Also Viewed